Eltrombopag fda approval date?

What was the FDA approval date for eltrombopag (Promacta/Revolade)?

The FDA approval date for eltrombopag is November 20, 2008. [1]

What is eltrombopag approved for?

Eltrombopag (Promacta/Revolade) was approved to treat thrombocytopenia in adults with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to other treatments, and later labels were added/expanded for other settings. [1]

Any quick context on brands and labeling?

Eltrombopag is marketed under brands including Promacta and Revolade depending on the indication and geography, but FDA approval timing refers to the original approval of the drug substance and its initial labeling under the FDA-approved product. [1]

Source

1. FDA Drug Approvals and Databases (Eltrombopag)